DRUG TESTING ASSESSMENT PROGRAM QUALITY CONTROL— 510(k) K913650

Substantially Equivalent

Duo Research, Inc.

FDA 510(k) clearance K913650 for DRUG TESTING ASSESSMENT PROGRAM QUALITY CONTROL, Substantially Equivalent on 1991-09-06. Applicant: Duo Research, Inc..

Clearance details

Applicant
Duo Research, Inc.
Product code
Code DIF
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Annapolis, MD, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.